Sirius XM Holdings Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation Plans and Awards (Tables)

Stock-based Compensation Plans and Awards (Tables)

3 Months Ended

Apr. 30, 2013

Stock-based Compensation Plans and Awards

Schedule of assumptions used for estimating the fair value of stock options

	Three Months Ended April 30,
	2012		2013
Expected life (in years)	6.67		6.29
Risk-free interest rate	1.52	%	1.18	%
Expected volatility	57	%	58	%
Expected dividend yield	0	%	0	%

Schedule of stock option activity

	Options Outstanding Stock Options		Weighted- Average Exercise Price		Aggregate(1) Intrinsic Value
	(in thousands, except share and per share data)
Balance as of January 31, 2013	26,102,949		$	3.22	$	224,736
Granted	1,365,000		11.49
Exercised	(1,573,269	)	2.24
Cancelled	(210,962	)	7.82
Balance as of April 30, 2013	25,683,718		$	3.68	$	266,196
Equity awards available for grant at April 30, 2013	12,812,657

(1) Amounts represent the difference between the exercise price and the fair value of common stock at period end for all in the money options outstanding based on the fair value per share of common stock.

Schedule of activities for RSUs

	Number of Shares		Weighted- Average Grant-Date Fair Value
Unvested at January 31, 2013	5,511,709		$	10.57
Granted	3,958,634		12.46
Vested	(387,490	)	11.72
Canceled	(134,015	)	11.21
Unvested at April 30, 2013	8,948,838		$	11.35

Schedule of stock-based compensation expenses related to all employee and non-employee stock-based awards

Stock-based compensation expenses related to all employee and non-employee stock-based awards was as follows (in thousands):

	Three Months Ended April 30,
	2012		2013
	(unaudited)
Stock-based compensation expenses:
Cost of revenue - Other	$	263	$	456
Product development	986		1,763
Marketing and sales	2,930		4,848
General and administrative	1,321		314

Total stock-based compensation, recorded in costs and expenses	$	5,500	$	7,381

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References + Details